New drug cocktail aims to tame transplant complication
Disease control
Not yet recruiting
This phase 2 trial tests a combination of Gecacitinib (a pill) and a corticosteroid as the first treatment for grade II to IV acute graft-versus-host disease (aGVHD), a serious complication after a stem cell transplant. The study will enroll 25 adults who have recently received a…
Phase: PHASE2 • Sponsor: Bin Gu • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC